ARTICLE | Company News
ActivBiotics infectious news
February 4, 2008 8:00 AM UTC
ActivBiotics completed the sale of its fixed assets to an undisclosed buyer for about $300,000 in a Jan. 24 auction. Another auction will begin on March 14 for the company’s IP covering rifalazil, an...